Despite great attention given to the recent Zika virus (ZIKV) epidemic in the Americas, much remains unknown about its epidemiology and evolution, in part due to a lack of genomic data. We applied multiple sequencing approaches to generate 100 ZIKV genomes from clinical and mosquito samples from 10 countries and territories, greatly expanding the observed viral genetic diversity from this outbreak. We analyzed the timing and patterns of introductions into distinct geographic regions, confirming phylogenetic evidence for the origin and rapid expansion of the outbreak in Brazil 1 , and for multiple introductions from Brazil into Honduras, Colombia, Puerto Rico, other Caribbean islands, and the continental US. We find that ZIKV circulated undetected in many regions of the Americas for up to a year before the first locally transmitted cases were confirmed, highlighting the challenge of effective surveillance for this virus. We further characterize genetic variation across the outbreak to identify mutations with possible functional implications for ZIKV biology and pathogenesis.
Despite great attention given to the recent Zika virus (ZIKV) epidemic in the Americas, much remains unknown about its epidemiology and evolution, in part due to a lack of genomic data. We applied multiple sequencing approaches to generate 100 ZIKV genomes from clinical and mosquito samples from 10 countries and territories, greatly expanding the observed viral genetic diversity from this outbreak. We analyzed the timing and patterns of introductions into distinct geographic regions, confirming phylogenetic evidence for the origin and rapid expansion of the outbreak in Brazil 1 , and for multiple introductions from Brazil into Honduras, Colombia, Puerto Rico, other Caribbean islands, and the continental US. We find that ZIKV circulated undetected in many regions of the Americas for up to a year before the first locally transmitted cases were confirmed, highlighting the challenge of effective surveillance for this virus. We further characterize genetic variation across the outbreak to identify mutations with possible functional implications for ZIKV biology and pathogenesis.
Since its introduction into Brazil in 2013 1 , mosquito-borne ZIKV (Family: Flaviviridae) has spread rapidly throughout the Americas, causing hundreds of thousands of cases of ZIKV disease, as well as ZIKV congenital syndrome and likely other neurological complications [2] [3] [4] . Comparative phylogenomic analysis of ZIKV can reveal the trajectory of the outbreak and detect mutations that may be associated with new disease phenotypes or affect molecular diagnostics. Despite the nearly 60 years since its discovery and the scale of the recent outbreak, however, fewer than 100 ZIKV genomes have been sequenced directly from clinical samples. This is due in part to technical challenges posed by low viral loads (often orders of magnitude lower than in Ebola or dengue virus infection [5] [6] [7] , as well as issues of RNA preservation in samples collected without the unique requirements of sequencing in mind. Culturing the virus can greatly increase the material available for sequencing, but it can introduce artefacts and is time-consuming and difficult.
We sought to gain a deeper understanding of the viral populations underpinning the ZIKV epidemic by extensive genome sequencing of the virus directly from samples collected as part of ongoing surveillance. We initially pursued metagenomic RNA sequencing in order to capture both ZIKV and other potential co-infections in an unbiased way. In most of the 37 samples examined by this approach, however, the amount of ZIKV material was not sufficient for genome assembly. Unbiased RNA sequencing still proved valuable because it provided ZIKV data to verify results from other methods. We also observed 3 other viruses in 7 samples (Extended Data Table 1 ) in our metagenomic data; notably, these did not include chikungunya or dengue, viruses known to be cocirculating with ZIKV in many affected regions 8, 9 .
In order to capture sufficient ZIKV content for genome assembly, we turned to two targeted enrichment approaches: hybrid capture 10 and PCR amplicon-based sequencing 11 (amp-seq). We attempted to sequence ZIKV directly from 200 samples (192 clinical samples from confirmed and possible ZIKV disease cases and 8 mosquito pools) from across the epidemic in the Americas ( Fig. 1a and Supplementary Table 1 ). Because these approaches also enrich any contaminant ZIKV content, it was critical that we take steps to avoid creating artefactual sequence. For this purpose, we relied heavily on negative control samples, and established robust, methodspecific thresholds on coverage and completeness (Fig. 1b) ; these allowed us to identify high confidence ZIKV assemblies while discarding contamination. We assembled complete or partial genomes from 100 samples, which we used for further analysis. This dataset includes 97 genomes enriched by amp-seq (out of 197 attempted) and a partially overlapping set of 30 genomes enriched by hybrid capture (out of 37 attempted). Patient sample type (urine, serum or plasma) made no significant difference in sequencing success (Extended Data Fig. 1 ). Completeness and coverage for these genomes are shown in Fig. 1c and d ; the median fraction of the genome with unambiguous base calls was 94%. Per-base discordance between genomes produced by the two methods was 0.0082% across the genome, 0.080% at polymorphic positions, and 1.1% for minor allele base calls. Concordance of within-sample variants is shown in more detail in Fig. 1e and f.
To investigate the spread of ZIKV in the Americas we performed a phylogenetic molecular clock analysis on the 100 genomes from our dataset, together with 64 published and available genomes from NCBI GenBank and our companion papers 12, 13 (Fig. 2a ). The resulting phylogenetic reconstruction (Fig. 2b) is consistent with the outbreak having started in Brazil: Brazil ZIKV genomes appear on all deep branches of the tree, and their most recent common ancestor occurs at the root of the entire tree. Estimated time to the most recent common ancestor (tMRCA) dates it in late 2013 (95% credible interval, CI, in decimal years [2013. 39, 2014.30] ). Low posterior probabilities of ancestral nodes near the root provide little support for stratification early in the outbreak, particularly in Brazil; this suggests rapid early spread, consistent with the introduction of a new virus in an immunologically naive population. ZIKV genomes from Colombia (n=10), Honduras (n=14), and Puerto Rico Figure 1 | Sequence data generated directly from clinical and mosquito samples. 200 clinical and mosquito pool samples were sequenced using amp-seq and/or hybrid capture, generating 100 ZIKV genomes. (a) For each country or territory, the number of genomes generated by each sequencing method. Each genome counted is from a sample that has at least one "positive" assembly, i.e. a replicate passes thresholds in (b). The "Other" category includes all samples from countries that did not produce a positive assembly. In the final column, genomes are counted only once if both methods produced a positive assembly. (b) Thresholds used to select samples for downstream analysis. Each point is a replicate. Red and blue shading: regions of accepted amp-seq and hybrid capture genome assemblies, respectively; purple: positive assemblies by either method. (n=3) each cluster into distinct clades. We also observed a clade consisting entirely of samples from 3 Caribbean countries (the Dominican Republic, Jamaica, and Haiti) and the continental US. This clade contains most of the genomes from the Dominican Republic (29 of 31) and the continental US (15 of 16). We estimated the withinoutbreak substitution rate to be 1.0x10 -3 substitutions/site/year (95% CI [8.5x10 -4 , 1.2x10 -3 ]), consistent with prior estimates 1 . Root-to-tip divergence based on genomes from Southeast Asia, the Pacific, and the Americas supports the use of a molecular clock analysis (Extended Data Fig. 2 ).
Principal component analysis (PCA) of the same genomes is consistent with the phylogenetic observations ( Fig.  2c and Extended Data Fig. 3 ). We observed tight clustering among ZIKV from the continental US, the Dominican Republic, and Jamaica. ZIKV genomes from Brazil, Colombia, and Puerto Rico are similar and distinct from genomes sampled in other countries. ZIKV from Honduras forms a third cluster that contains genomes from Guatemala or El Salvador. The PCA results also show no clear stratification of genomes within Brazil.
Determining when ZIKV arrived in specific regions is important for understanding the epidemiology of the virus; more importantly, it tells researchers when and where to look for rising incidence of possible complications of ZIKV infection. We estimated the tMRCA for well-supported nodes within our phylogeny, including four highly supported clades (posterior probability >0.95), formed mostly by strains from Colombia, Honduras, Puerto Rico, the Caribbean, and the continental US. We found that these four clades originated in early to mid 2015, several months before the first ZIKV cases were confirmed in these regions, indicating ongoing local circulation of ZIKV before its detection by surveillance systems. We estimated tMRCA of ZIKV 30, 2015 .78]), 5 months before the first confirmed locally transmitted cases 16 . We estimated tMRCA of the Caribbean clade, consisting of genomes from three Caribbean countries and the continental US, to be in February 2015 (95% CI [2014.76, 2015.52]), 11 months before the first confirmed case in the Dominican Republic 17 and more than a year before the first confirmed case in Florida, USA 18 . We observed several introductions of ZIKV into the continental US and found that sequences from mosquito and human samples collected in Florida cluster together; this suggests local ZIKV transmission in Florida and is consistent with findings detailed in a companion paper 13 . Similar temporal gaps between the tMRCA of local transmission chains and the detection of early cases were observed in the emergence of chikungunya virus in the Americas 19 .
Analysis of genetic variation can provide important clues to understanding ZIKV biology and pathogenesis, and may reveal potentially functional changes in the virus. Using the same dataset from 164 outbreak samples, we observed 1007 single nucleotide polymorphisms (SNPs), well distributed across the genome (Fig. 3a) . These included 198 nonsynonymous SNPs (Supplementary Table 2 ) and 31 variants in the 5' and 3' untranslated regions (UTRs). We observed 4 positions with nonsynonymous mutations (at >5% frequency) that occur on two or more branches of the tree (Fig. 3b ); two of these (at 4287 and 8991) occur together and might represent incorrect placement of a Brazil branch in the tree. The remaining two are more likely to represent multiple nonsynonymous mutations; one (at 9240) appears to involve nonsynonymous mutations to 2 different alleles.
To assess possible biological significance of these mutations, we looked for evidence of selection on the ZIKV genome. In particular, we searched for an excess of nonsynonymous mutations in the envelope (E) protein coding region; positive selection due to host antibody binding to this ZIKV surface protein could drive nonsynonymous changes there, as seen in other viral glycoproteins [20] [21] [22] . However, the nonsynonymous substitution rate in E proved to be similar to that in the rest of the coding region ( Fig. 3c , left); moreover, amino acid changes were significantly more conservative in the region than elsewhere (Fig. 3c , middle and right). Any diversifying selection that is occurring in the surface protein appears to be operating under substantial selective constraint. In the ZIKV 3' UTR, we also found evidence for purifying selection ( Fig. 3d and Supplementary Table 3 ); this confirms the functional importance of the region, which has previously been reported to play a role in viral replication 23 . ZIKV genomes. Cell color indicates that a sample's allele matches the probe/primer sequence (grey), differs from it (red), or has no data for that position (white).
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Minor allele frequency While the transition-to-transversion ratio, which had a value of 7.0, was within the range seen in other viruses 24 , we observed a significantly higher frequency of C-to-T and T-to-C substitutions than other transitions ( Fig. 3d , Extended Data Fig. 4 , Supplementary Table 3 ). This enrichment is apparent both in the genome as a whole and at 4-fold degenerate sites, where selection pressure is minimal. Many processes are possible contributors to this conspicuous mutation pattern, including mutational bias of the ZIKV RNA-dependent RNA polymerase, host RNA editing enzymes (e.g., APOBECs, ADARs) acting upon viral RNA, and chemical deamination, but further work is required to determine the actual cause of this phenomenon.
One potential concern for ZIKV surveillance is that genetic changes to the virus could reduce the sensitivity of diagnostic tests, which are based on specific viral RNA sequences. Accordingly, we evaluated 8 published qRT-PCR-based primer/probe sets in silico using all ZIKV genomes from this outbreak ( Fig. 3e ). We did find mutations in diagnostic regions that occurred during the outbreak, but they were all present at low frequencies.
The bulk of mismatches between assays and ZIKV sequence appears to be the result of nucleotides that are fixed in the Americas. These observations suggest that diagnostic assays used in the Americas should be chosen with care, and should be systematically reevaluated and updated regularly 25 .
Accurately calling within-host virus genetic diversity is important for understanding virus-host interactions and viral transmission. Therefore, in addition to the between-sample variants described above, we examined genetic variation within samples. We observed high concordance between the methods we used -amp-seq and hybrid capture -for base calls in our genome assemblies, including calls at polymorphic sites. By contrast, we found that most within-sample variants did not replicate between methods or between technical replicates ( Fig. 1e-f and Extended Data Table 2 ). Even so, there is good reason to think that useful information about within-sample variation is accessible: when alleles do replicate, estimates of their frequency show good concordance (RMSE <5% in both methods). Imposing a previously described filter 26 eliminated all hybrid capture alleles not validated by a second replicate, but naively using these filters on amp-seq data had little effect (49% of alleles remain unvalidated). These results suggest that while these methods identify real within-sample variants, they also detect many spurious ones; current filtering can separate true from spurious hybrid capture variants, but technical improvements are needed to either reduce amp-seq noise or computationally filter it.
Sequencing low titer viruses like ZIKV directly from clinical samples presents several challenges, which have likely contributed to the paucity of genomes available from the current outbreak. While development of technical and analytical methods will surely continue, we note that factors upstream in the process, including collection site and cohort, were strong predictors of sequencing success (Extended Data Fig. 1 ). This suggests that study design and sample handling processes are key for this application of sequencing, and further that developing and implementing best practices for sample handling, without disrupting standard clinical workflows, will be vital to wider adoption of genome surveillance during outbreaks, especially for low titer viruses. Additional sequencing, however challenging, remains critical to ongoing investigation of ZIKV biology and pathogenesis. Together with two companion studies 12, 13 , this effort advances both technological and collaborative strategies for genomic surveillance in the face of unexpected outbreak challenges.
Methods
Ethics statement
The clinical studies from which samples were obtained were evaluated and approved by relevant by Institutional Review Boards/Ethics Review Committees at Hospital General de la Plaza de la Salud (Santo Domingo, Dominican Republic), University of the West Indies (Kingston, Jamaica), Universidad Nacional Autónoma de Honduras (Tegucigalpa, Honduras), Oswaldo Cruz Foundation (Rio de Janeiro, Brazil), Centro de Investigaciones Epidemiologicas -Universidad Industrial de Santander (Bucaramanga, Colombia), Massachusetts Department of Public Health (Jamaica Plain, Massachusetts), and Florida Department of Health (Tallahassee, Florida). Harvard University and Massachusetts Institute of Technology (MIT) Institutional Review Boards/Ethics Review Committees provided approval for sequencing and secondary analysis of samples collected by the aforementioned institutions.
Sample collections and study subjects
Suspected ZIKV cases (including high-risk travelers) were enrolled through study protocols at multiple aforementioned collection sites. Clinical samples (including blood, urine, cerebrospinal fluid, and saliva) were obtained from suspected or confirmed ZIKV cases and from high-risk travelers. De-identified information about study participants and other sample metadata are reported in Supplementary Table 1 .
Viral RNA isolation
Viral samples were inactivated in AVL buffer (Qiagen) following standard operating protocol (0.2 mL sample) or large volume method (1 mL sample, Massachusetts Department of Health 27 ). RNA (from AVL) was isolated using the QIAamp Viral RNA Minikit (Qiagen) according to the manufacturer's protocol, except that in some cases 0.1 M final concentration of β-mercaptoethanol was added to AVL buffer prior to inactivation, and in some cases 40 µg/mL final concentration of linear acrylamide (Ambion) was added. Extracted RNA was resuspended in water.
Carrier RNA and host rRNA depletion
In a subset of human samples, carrier poly(rA) RNA and host rRNA were depleted from RNA samples using RNase H selective depletion 10, 28 . Briefly, oligo d(T) (40 nt long) and/or DNA probes complementary to human rRNA were hybridized to the sample RNA. The sample was then treated with 15 units of Hybridase Thermostable RNase H (Epicentre) for 30 minutes at 45°C. The complementary DNA probes were removed by treating each reaction with RNase-free DNase kit (Qiagen) according to the manufacturer's protocol. Following depletion, samples were purified using 1.8x volume AMPure RNAclean beads (Beckman Coulter Genomics) and eluted into 10 µl water for cDNA synthesis.
Illumina library construction and sequencing
cDNA synthesis was performed as described in previously published RNA-seq methods 10 . To track potential crosscontamination, 50 fg of synthetic RNA (ERCC, gift from M. Salit, NIST) was spiked into samples, using unique RNA for each individual ZIKV sample. Positive and negative control cDNA libraries were prepared from water, human K-562 total RNA (Ambion), ZIKV Senegal (HD78788) seed stock, Pernambuco (KX197192.1) seed stock, and EBOV Makona (KY425633.1) seed stock. The dual index Accel-NGS® 2S Plus DNA Library Kit (Swift Biosciences) was used for library preparation. Approximately half of the cDNA product was used for the library construction, and indexed libraries were generated using 18 cycles of PCR. Each individual sample was indexed with a unique barcode. Libraries were pooled equally based on molar concentration and sequenced on the Illumina HiSeq 2500 or MiSeq (paired-end reads) platforms.
Amplicon-based cDNA synthesis and library construction
ZIKV amplicons were prepared as described 11, 13 with slight modifications. After PCR amplification, each amplicon pool was quantified on a 2200 Tapestation (Agilent Technologies) using High Sensitivity D1000 ScreenTape (Agilent Technologies). 2 µL of a 1:10 dilution of the amplicon cDNA was loaded and the concentration of the 350-550 bp fragments was calculated. The cDNA concentration, as reported by the Tapestation, was highly predictive of ZIKV positivity as determined by sequencing (Extended Data Fig. 5 ). cDNA from each of the two amplicon pools were mixed equally (10-25 ng each) and libraries were prepared using the dual index Accel-NGS® 2S Plus DNA Library Kit (Swift Biosciences) according to protocol. Libraries were indexed with a unique barcode using 7 cycles of PCR, pooled equally and sequenced on the Illumina MiSeq (250 bp paired-end reads) platform. Primer sequences were removed by hard trimming the first 30 bases for each insert read prior to analysis.
Zika virus hybrid capture
Viral hybrid capture was performed as previously described 10 . Probes were created to target ZIKV and chikungunya virus (CHIKV). Candidate probes were created by tiling across publicly available sequences for ZIKV and CHIKV (on GenBank). Probes were selected from among these candidate probes to minimize the number used while maintaining coverage of the observed diversity of the viruses. Alternating universal adapters were added to allow two separate PCR amplifications, each consisting of non-overlapping probes. (To download probe sequences, see Supplementary Information.)
The probes were synthesized on a 12k array (CustomArray). The synthesized oligos were amplified by two separate emulsion PCR reactions with primers containing T7 RNA polymerase promoters. Biotinylated baits were in vitro transcribed (MEGAshortscript, Ambion) and added to prepared ZIKV libraries. The baits and libraries were hybridized overnight (~16 hrs), captured on streptavidin beads, washed, and re-amplified by PCR using the Illumina adapter sequences. Capture libraries were then pooled and sequenced. Since samples often contained only a few ZIKV reads, a second round of hybrid capture was occasionally attempted (Extended Data Fig. 6 ). In the main text, "hybrid capture" refers to a combination of hybrid capture sequencing data and data from the same libraries without capture (unbiased), unless explicitly distinguished.
Genome assembly
We assembled reads from all sequencing methods into genomes using viral-ngs v1.13.3 29, 30 . We taxonomically filtered reads from amp-seq against KU321639.1; we filtered reads from other approaches against the list of accessions provided in Supplementary Information. To compute results on individual replicates, we de novo assembled these and scaffolded against the KU321639.1 reference genome. To obtain final genomes for analysis, we pooled data from multiple replicates of a sample, de novo assembled, and scaffolded against KX197192.1. For all assemblies, we set the viral-ngs 'assembly_min_length_fraction_of_reference' and 'assembly_min_unambig' parameters to 0.01. For amp-seq, unambiguous base calls required at least 90% of reads to agree in order to call that allele ('major_cutoff' = 0.9); for hybrid capture data, we used the default threshold of 50%. We modified viral-ngs so that calls to GATK's UnifiedGenotyper set 'min_indel_count_for_genotyping' to 2.
At 3 sites with insertions or deletions (indels) in the consensus genome CDS, we corrected the genome with results from Sanger sequencing (namely, at 3447 in DOM_2016_BB-0085-SER; at 5469 in BRA_2016_FC-DQ12D1-PLA; and at 6516-6564 in BRA_2016_FC-DQ107D1-URI, with coordinates in KX197192.1). At other indels, we replaced the indel with ambiguity.
Depth of coverage values from amp-seq include PCR and optical duplicates. In all other cases, we removed duplicates with viral-ngs.
Identification of non-ZIKV viruses in samples by unbiased sequencing
Using Kraken v0.10.6 31 in viral-ngs, we built a database that includes its default "full" database (which incorporates all bacterial and viral whole genomes from RefSeq 32 as of October 2015). Additionally, we included the whole human genome (hg38), genomes from PlasmoDB 33 , sequences covering mosquito genomes (Aedes aegypti, Aedes albopictus, Anopheles albimanus, Anopheles quadrimaculatus, Culex quinquefasciatus, and the outgroup Drosophila melanogaster) from GenBank 34 , protozoa and fungi whole genomes from RefSeq, SILVA LTP 16s rRNA sequences 35 , and all sequences from NCBI's viral accession list (as of October 2015) for viral taxa that have human as a host. (To download database, see Supplementary Information.)
For each replicate of unbiased sequencing data per sample (not including hybrid capture data), we ran Kraken and searched its output reports for viral taxa with more than 100 reported reads. We manually filtered the results, removing ZIKV, bacteriophages, and lab contaminants. For each sample and its associated taxa, we assembled genomes using viral-ngs as described above. We used the following genomes for taxonomically filtering reads and as the reference for assembly: KJ741267.1 (cell fusing agent virus), AY292384.1 (deformed wing virus), LC164349.1 (JC polyomavirus). When reporting sequence identity of an assembly with its taxon, we used the identity determined by BLASTN 36 when the assembly is compared against the reference genome used for its assembly.
Relationship between metadata and sequencing outcome
To determine if available sample metadata are predictive of sequencing outcome, we tested the following variables: sample collection site, patient gender, patient age, sample type, and the number of days between symptom onset and sample collection ("collection interval"). To describe sequencing outcome of a sample S, we used the following response variable Table 1 under "dependent variable used in regression on metadata". We excluded the saliva and cerebrospinal fluid sample types due to sample number (n=1), the samples from mosquito pools, and rows with missing values. We treated samples with type "Plasma EDTA" as having type "Plasma". We treated the "collection interval" variable as categorical (0-1, 2-3, 4-6, and 7+ days).
With a single model we underfit the zero counts, possibly because many zeros (no positive ZIKV assembly) are truly ZIKVnegative. We thus view the data as coming from two processes: one determining whether a sample is ZIKV-positive or ZIKV-negative, and another that determines, among the observed positive samples, how much of a ZIKV genome we are able to sequence. We modeled the first process with logistic regression (in R using GLM 37 with binomial family and logit link); the positive observed samples are the samples S for which Y S ≥ 2500. For the second, we performed a beta regression, using only the positive observed samples, of Y S divided by ZIKV genome length on the predictor variables. We implemented this in R using the betareg package 38 To test the significance of predictor variables, we used a likelihood ratio test. For variable X i we compared a full model (with all predictors) against a model that uses all predictors except X i . Results are shown in Extended Data Fig. 1 .
Visualization of coverage depth across genomes
For amp-seq data, we plotted coverage across 97 samples that yielded a positive assembly by either method and for which we have amp-seq data (Fig. 1c) . With viral-ngs, we aligned depleted reads to the reference sequence KX197192.1 using the novoalign aligner with options '-r Random -l 40 -g 40 -x 20 -t 100 -k'. There was no duplicate removal. We binarized depth at each nucleotide position, showing red if depth of coverage is at least 500x. Rows (samples) are hierarchically clustered to ease visualization.
For hybrid capture sequencing data, we plotted depth of coverage across the 32 samples that yielded a positive assembly by either method and for which we have hybrid capture data (Fig. 1d ). (This is 2 more than the 30 samples that were positive based on their hybrid capture data.) We aligned reads as described above for amp-seq data, except we removed optical and PCR duplicates. For each sample, we calculated depth of coverage at each nucleotide position. We then shifted the values for each sample so that its mean depth is 0. At each nucleotide position in KX197192.1, we calculated the mean and standard deviation of the resulting values. We plotted the mean of these metrics within a 80 nt sliding window.
Criteria for pooling across replicates
We attempted to sequence one or more replicates of each sample and attempted to assemble a genome from each replicate. We discarded data from any replicates whose assembly showed high sequence similarity, in any part of the genome, to our assembly of a sample consisting of an African (Senegal) lineage (strain HD78788). We used this sample as a positive control throughout this study, and we considered its presence in the assembly of a clinical or mosquito pool sample to be evidence of contamination. We also discarded data from replicates that show evidence of contamination, at the RNA stage, by the baits we used for hybrid capture; we detected these by looking for adapters that were added to these probes for amplification.
For amp-seq, we consider an assembly positive if it contains at least 2500 unambiguous base calls and has a median depth of coverage of at least 500x over its unambiguous bases (depth is calculated including duplicate reads). For the unbiased and hybrid capture approaches, we consider an assembly of a replicate positive if it contains at least 4000 unambiguous base calls at any coverage depth. For each approach, we selected the unambiguous base threshold based on an observed density of negative controls below the threshold (Fig. 1b) . For amp-seq assemblies, we added a threshold on depth of coverage because coverage depth was roughly binary across replicates, with negative controls falling in the lower class. Based on these thresholds, we found that 0 of 87 negative controls used throughout our sequencing runs yield positive assemblies and that 29 of 29 positive controls yield positive assemblies.
We consider a sample to have a positive assembly if any of its replicates, by either method, yields an assembly that passes the above thresholds. For each sample with at least one positive assembly, we pooled read data across replicates for each sample, including replicates with assemblies that do not pass the positivity thresholds. When data was available from both amp-seq and unbiased/hybrid capture approaches, we pooled amp-seq data separately from data produced by the unbiased and hybrid capture approaches, the latter two of which were pooled together (henceforth, the "hybrid capture" pool). We then assembled a genome from each set of pooled data. When assemblies on pooled data were available from both approaches, we selected the assembly from the hybrid capture approach if it had more than 10267 unambiguous base calls (95% of the reference, GenBank accession KX197192.1); when both assemblies had fewer than this number of unambiguous base calls, we selected the one that had more unambiguous base calls.
The number of ZIKV genomes publicly available prior to this study is the result of a GenBank 34 search for ZIKV in February 2017. We filtered any sequences with length <4000 nt, excluded sequences that are being published as part of this study or a co-submission, and excluded sequences labeled as having been passaged. We counted <100 sequences.
Multiple sequence alignments
We aligned ZIKV consensus genomes using MAFFT v7.221 39 with the following parameters: '--maxiterate 1000 --ep 0.123 --localpair'.
In Supplementary Data, we provide all sequences and alignments used in analyses.
Analysis of within-and between-sample variants
To measure overall per-base discordance between consensus genomes produced by amp-seq and hybrid capture, we considered all sites where base calls were made in both the amp-seq and hybrid capture consensus genomes of a sample, and we calculated the fraction in which the bases were not in agreement. To measure discordance at polymorphic sites, we took all of the consensus genomes generated in this study that we selected for downstream analysis and searched for positions with polymorphism (see Criteria for pooling across replicates for choosing among the amp-seq and hybrid capture genome when both are available). We then looked at these positions in genomes that were available from both methods, and we calculated the fraction in which the alleles were not in agreement. To measure discordance at minor alleles, we took all of the consensus genomes generated in this study that we selected for downstream analysis and searched for minor alleles. We then looked at all sites at which there was a minor allele and for which genomes from both methods were available, and we calculated the fraction in which the alleles were not in agreement. For both calculations, we tolerated partial ambiguity (e.g., 'Y' is concordant with 'T'). If one genome had full ambiguity ('N') at a position and the other genome had an indel, we counted the site as discordant; otherwise, if one genome had full ambiguity, we did not count the site.
After assembling genomes, we determined within-sample allele frequencies for each sample by running V-Phaser 2.0 (via viral-ngs) on all pooled reads mapping to the sample assembly. When comparing allele frequencies between replicate libraries, we included only samples with two or more replicates. Similarly, the comparison of alleles across methods included only samples that have a positive assembly by either method and for which we have data from both methods. For these comparisons, we only included positions with a minor variant; i.e. positions for which both libraries/methods had an allele at 100% were removed, even if the single allele differed between the two libraries/methods. Additionally, we considered any allele with frequency <0.5% as not found (0%).
When comparing allele frequencies across methods: let f a and f hc be frequencies in amp-seq and hybrid capture, respectively. If both are nonzero, we only included an allele if the sequencing depth at its position was ≥1/min(f a , f hc ) in both methods. If f a =0, we required a sequencing depth of 1/f hc at the position in the amp-seq method; similarly, if f hc =0 we required a sequencing depth of 1/f a at the position in the hybrid capture method. This was to eliminate lack of coverage as a reason for discrepancy between two methods. When comparing allele frequencies across sequencing replicates within a method, we eliminated effects of low coverage by imposing a minimum coverage depth in both libraries at the position in question: 500x for amp-seq; 100x for hybrid capture. In samples with more than two replicates, we only considered the two replicates with the highest coverage at a particular site for each allele.
We considered allele frequencies from hybrid capture sequencing "verified" if they passed the strand bias and frequency filters described in Gire et al. 2014 26 , with the exception that we allowed a variant identified in only one library if its frequency was ≥5%. In Fig. 1f we applied the same strand bias filter but not the minimum frequency filter. In Fig. 1e and 1f, we considered variants "validated" if they were present at above 0.5% frequency in both libraries or methods. When comparing two libraries for a given method M (amp-seq or hybrid capture): the proportion unvalidated is the fraction, among all variants in M at ≥0.5% frequency in at least one library, of the variants that are at ≥0.5% frequency in exactly one of the two libraries. Similarly, when comparing methods: the proportion unvalidated for a method M is the fraction, among all variants at ≥0.5% frequency in M, of the variants that are at ≥0.5% frequency in M and <0.5% frequency in the other method. The root mean squared error (RMSE) includes only variants found in both methods or replicates (i.e. does not include unvalidated variants). Restricting the sample set used for comparison of variants across libraries to only samples with a positive assembly in both methods had no significant impact on the results.
We initially called SNPs on the aligned consensus genomes using Geneious version 9.1.7 40 . We converted all fully or partially ambiguous calls, which are treated by Geneious as variants, into missing data. We then removed all sites that were no longer polymorphic from the SNP set and re-calculated allele frequencies. A nonsynonymous SNP is shown on the tree (Fig. 3b) if it includes an allele that is nonsynonymous relative to the ancestral state (see Molecular clock phylogenetics and ancestral state reconstruction section below) and has an allele frequency of >5%; all occurrences of nonsynonymous alleles are shown. We placed mutations at a node such that the node leads only to samples with the mutation or with no call at that site. Uncertainty in placement occurs when a sample lacks a base call for the corresponding SNP; in this case, we placed the SNP on the most recent branch for which we have available data. We also used this ancestral ZIKV state to count the frequency of each type of substitution over various regions of the ZIKV genome, per number of available bases in each region ( Fig. 3d and Supplementary Table 3 ).
We quantified the effect of nonsynonymous SNPs using the original BLOSUM62 scoring matrix for amino acids 41 , in which positive scores indicate conservative amino acid changes and negative scores unlikely or extreme substitutions. We assessed statistical significance for equality of proportions by χ 2 test (Fig. 3c, middle) , and for difference of means by 2-sample t-test with Welch-Satterthwaite approximation of df (Fig. 3c, right) . Error bars are 95% confidence intervals derived from binomial distributions (Fig. 3c , left and middle) or Student's t-distributions ( Fig. 3c, right) . In Fig. 3d , error bars are 95% confidence intervals derived from binomial distributions.
Maximum likelihood estimation and root-to-tip regression
We generated a maximum likelihood tree using a multiple sequence alignment that includes sequences generated in this study, as well as a selection of other available sequences from the Americas, Southeast Asia, and the Pacific. (See the sequences listed in Supplementary Information.) We ran IQ-TREE 42 with options '-m HKY+G4 -bb 1000' 43 . In FigTree v1.4.2 44 , we rooted the tree on the oldest sequence used as input (GenBank accession EU545988.1).
We used TempEst v1.5 45 , which selects the best-fitting root with a residual mean squared function (also EU545988.1), to estimate root-to-tip distances. We performed regression in R with the lm function 37 of distances on dates.
In Supplementary Data, we provide the output of IQ-TREE, as well as the dates and distances used for root-to-tip regression.
Molecular clock phylogenetics and ancestral state reconstruction
For molecular clock phylogenetics, we made a multiple sequence alignment from the sequences generated in this study combined with a selection of other available sequences from the Americas. (See the sequences listed in Supplementary Information.)
We used BEAST v1.8.2 to perform molecular clock analyses 46 . We used the SDR06 substitution model on the CDS, which uses HKY with gamma site heterogeneity and partitions codons into two partitions (positions (1+2) and 3) 47 . For the noncoding regions, we used a HKY substitution model with gamma site heterogeneity and no codon partitioning. We used a strict clock model with a Bayesian Skyline tree prior (10 groups, piecewise-constant model) 48 . We set the molecular clock rate to use a continuous time Markov chain rate reference prior 49 . We ran BEAST twice, each with 75 million MCMC steps and sampling set to every 10,000 th step, to verify convergence. We then removed the first 7.5 million states (10%) from each run as burn-in and combined the samples from the two runs. We extracted clock rate and tMRCA estimates, and their distributions, with Tracer v1.6.0 and identified the maximum clade credibility (MCC) tree using TreeAnnotator v1.8.2. The reported credible intervals around estimates are 95% highest posterior density (HPD) intervals.
We used BEAST v1.8.2 to estimate transition and transversion rates. The model was the same as above except that we used the Yang96 substitution model on the CDS, which uses GTR with gamma site heterogeneity and partitions codons into three partitions 50 ; for the noncoding regions, we used a GTR substitution model with gamma site heterogeneity and no codon partitioning. There were four partitions in total: one for each codon position and another for the noncoding region. The number of steps, sampling, and burn-in was the same as above. At each sampled step of the MCMC, we calculated substitution rates for each partition using the overall substitution rate, the relative substitution rate of the partition, the relative rates of substitutions in the partition, and base frequencies. In Extended Data Fig. 4 , we plot the means of these rates over the steps; the error bars shown are 95% HPD intervals of the rates over the steps.
We used BEAST v1.8.2 to reconstruct ancestral state at the root of the tree. The model was the same as the first described in this section except that, on the CDS, we used the HKY substitution model with gamma site heterogeneity and codons partitioned into three partitions (one per codon position). We ran BEAST twice, each with 40 million MCMC steps and sampling every 10,000 th step, to verify convergence. We then removed the first 4 million states (10%) from each run as burnin. On each run, we used TreeAnnotator v1.8.2 to find the state with the MCC tree. We selected the run with the higher log clade credibility for its MCC tree and used the ancestral state from this run.
In Supplementary Data, we provide BEAST input (XML) and output files. We also provide the sequence of the reconstructed ancestral state.
Principal component analysis
We carried out principal component analysis using the R package FactoMineR 51 . We imputed missing data with the package missMDA 52 . Removing the two most extreme outlier samples from the plot clarified population structure, and we show the results in Fig. 2c ; we show the PC distribution for all samples in Extended Data Fig. 3 . Removing additional outliers had little effect.
Diagnostic assay assessment
We extracted primer and probe sequences from eight published qRT-PCR assays [53] [54] [55] [56] [57] [58] and aligned to our ZIKV genomes using Geneious version 9.1.7 40 . We then tabulated matches and mismatches to the diagnostic sequence for all outbreak genomes, allowing multiple bases to match where the diagnostic primer and/or probe sequence contained nucleotide ambiguity codes (Fig. 3e ).
Data availability
Sequence data that support findings of this study will be deposited in GenBank prior to publication, and accession numbers will be listed here (BioProject accession PRJNA344504). Samples collected 7+ days after symptom onset produced, on average, the fewest unambiguous bases, though these observations are based on a limited number of data points. While the sample site variable accounts for differences in the composition of cohorts, the observed effects of gender and collection interval might be due to confounders in cohort composition that span multiple cohorts. A>T  T>A  C>G  G>C  G>T  T>G  A>G  G>A  C>T  T>C  A>C  C>A  A>T  T>A  C>G  G>C  G>T  T>G  A>G  G>A  C>T  T>C  A>C  C>A  A>T  T>A  C>G  G>C  G>T  T>G  A>G  G>A  C>T  T>C  A>C  C>A  A>T  T>A  C>G  G>C  G>T  T>G  A>G  G>A  C>T Extended Data Table 1 | Viruses other than Zika uncovered by unbiased sequencing. Three viral species other than Zika were found by unbiased sequencing of 37 samples. Column 3: the number of reads in a sample that belong to the species as a raw count and a percent of total reads. Column 4: the percent genome assembled based on the number of unambiguous bases called. Cell fusing agent virus (a Flavivirus) and deformed wing virus were in mosquito pools, and JC polyomavirus was in clinical samples. All assemblies had ≥95% sequence identity to a reference sequence for the listed species, except cell fusing agent virus in USA_2016_FL-06-MOS (91%). 
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